
SABS Stock Price Prediction
SAB Biotherapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
1-Day-Price-Prediction
+0.19%
1-Week Prediction
-1.72%
Based on our advanced algorithm, we predict that SABS stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $2.61, while the 1-week outlook suggests a value of $2.57. For the 1-month forecast, we project a price of $2.6. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
2.600
Should I Buy SAB Biotherapeutics Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. SABS has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
SABS stock price ended at $2.61 on Tuesday, after losing -3.33%
The SAB Biotherapeutics Inc stock price decreased by -3.33% on the last trading day (22 Jul 2025), dropping from 2.57 to 2.61. Throughout the last trading session, the stock experienced a fluctuation of 19.82% , ranging from a day low of $2.245 to a day high of 2.69. The price has declined in 5 of the last 10 days, resulting in a total change of 1.16% during this period. On the last day, trading volume decrease by -80.28M shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.43M shares were traded, amounting to approximately 3.42M.
SABS Technical Signals
SABS(SAB Biotherapeutics Inc Corp) has 5 buy signals and 2 sell signals now. The current trend is downtrend starting from 2025-07-16. The total price change during this trend is -6.45%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of SABS over the last 5 trading days is 44.91M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
SABS Moving Average Analysis
SAB Biotherapeutics Inc's overall moving average trend leans more bearish as of Wednesday, July 23, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $6.52, and $8.18. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.14, and $-0.53. A break-down below any of these levels will issue sell signals.
SABS Short Selling Analysis
The short sale ratio of SAB Biotherapeutics Inc(SABS) as of 17 Jul 2025 is 8.59%, dropping from last trading day. With decreasing price from 2.79 to 2.84. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary

Buy
Sell
2
Buy
5
Moving Average
Swing

Stock Price Below SMA_5
Short Term

SMA_5 Above SMA_20
Mid Term

SMA_20 Above SMA_60
Long Term

SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.953
Bullish
Momentum (10 days)
MOM_10 > 0
0.03
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.239
Bullish
Williams %R (14 days)
WILLR_14 < -80
-81.679
Bullish
Ultimate Oscillator (7, 14, 28)
UO_7_14_28 < 30
25.861
Bullish
2 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Moving Average
Price crosses below 5-day SMA
--
Bearish
Moving Average
Price crosses below 10-day SMA
--
Bearish
SABS Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, SAB Biotherapeutics Inc (SABS) is anticipated to change hands in a trading channel between $0.00 and $0.00.
SAB Biotherapeutics Inc Stock Forecast 2026
SABS Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to SAB Biotherapeutics Inc(SABS), our algorithm predicts SABS's 1-month price at $1.36, with an -47.25%downwardshift. Using a similarity score up to 98.76%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for SAB Biotherapeutics Inc (SABS.O) stock, as of Sunday, July 20, 2025 , forecasts a -47.25% change over the next month, based on its high correlation with NOTV.O stock patterns. The similarity between their price movements over the analyzed periods is 98.76%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

SABS
Future prediction
Up: -47.25%

NOTV
Down: -47.25%Similarity: 98.76%
Name
Similarity
Up/Down

NOTV.O
98.76%
-47.25%

SAN.N
98.70%
-3.99%

DXPE.O
98.64%
-14.77%

REI.A
98.47%
+2.68%

ATLO.O
98.43%
+1.90%

RAMP.N
98.42%
+5.11%

NWS.O
98.41%
-10.60%

ATS.N
98.40%
+14.70%

PRMB.N
98.38%
-10.32%

ARLP.O
98.38%
+47.53%
SABS Seasonality Analysis
Based on SABS's historical stock price data across all years, the probability of a positive return in July is20.00%, suggesting it maynotbe an ideal month to invest in SABS. In contrast,Octoberoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying SAB Biotherapeutics Inc (SABS.O) stock in October has the highest probability of a positive return (75.00%), while February has the lowest probability (0.00%).
Performance Seasonality
The chart shows SAB Biotherapeutics Inc. (SABS)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch

MLEC
Moolec Science SA
3.260
USD
-13.07%

ECDA
ECD Automotive Design Inc
0.267
USD
-1.11%

GLE
Global Engine Group Holding Ltd
3.540
USD
+1.14%

FTHM
Fathom Holdings Inc
1.590
USD
+6.71%

APWC
Asia Pacific Wire & Cable Corporation Ltd
1.840
USD
+2.79%

BATL
Battalion Oil Corp
1.350
USD
+0.75%

FTEK
Fuel Tech Inc
2.690
USD
+1.51%

NTIP
Network-1 Technologies Inc
1.450
USD
+2.11%

ONMD
Onemednet Corp
0.541
USD
+1.12%

NMTC
NeuroOne Medical Technologies Corp
1.030
USD
+14.44%
FAQ

Should I buy SAB Biotherapeutics Inc (SABS.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. SABS has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

Which months have the highest win rate for buying SAB Biotherapeutics Inc (SABS.O) stock in a year?

How has SAB Biotherapeutics Inc. (SABS)'s stock price performed over the past three years?

Which bull technical signals does SABS have?

Which bearish technical signals does SABS have?

Is SABS a buy based on overall technical signals summary?

What is the trend of SAB Biotherapeutics Inc (SABS)'s moving average?

What is price prediction for SABS stock next month?

What is price prediction 2025 for SABS Stock?
